SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-031582
Filing Date
2022-11-14
Accepted
2022-11-14 07:02:40
Documents
67
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 802426
2 ex31-1.htm EX-31.1 23704
3 ex31-2.htm EX-31.2 23704
4 ex32-1.htm EX-32.1 9490
5 ex32-2.htm EX-32.2 8850
  Complete submission text file 0001493152-22-031582.txt   4030768

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cing-20220930.xsd EX-101.SCH 35631
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cing-20220930_cal.xml EX-101.CAL 57562
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cing-20220930_def.xml EX-101.DEF 136381
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cing-20220930_lab.xml EX-101.LAB 287715
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cing-20220930_pre.xml EX-101.PRE 219414
61 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 524435
Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Filer) CIK: 0001862150 (see all company filings)

IRS No.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40874 | Film No.: 221380085
SIC: 2834 Pharmaceutical Preparations